Academic Journal
A survey of community pharmacists perspectives on monitoring antidepressant adverse events.
| Τίτλος: | A survey of community pharmacists perspectives on monitoring antidepressant adverse events. |
|---|---|
| Συγγραφείς: | Verheye K; Clinical Pharmacology Unit, Department of Basic and Applied Medical Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Roesems L; Clinical Pharmacology Unit, Department of Basic and Applied Medical Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Van Caenegem L; Clinical Pharmacology Unit, Department of Basic and Applied Medical Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Johnson CF; Specialist Mental Health and Advanced General Practice Pharmacist, Primary Care, Pharmacy Services, National Health Service Greater Glasgow and Clyde, Glasgow, UK., Mehuys E; Pharmaceutical Care Unit, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium., Petrovic M; Department of Internal Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Boussery K; Pharmaceutical Care Unit, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium., Christiaens T; Clinical Pharmacology Unit, Department of Basic and Applied Medical Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Van Leeuwen E; Clinical Pharmacology Unit, Department of Basic and Applied Medical Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.; Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium. |
| Πηγή: | British journal of clinical pharmacology [Br J Clin Pharmacol] 2026 Jul; Vol. 92 (7), pp. 2403-2408. Date of Electronic Publication: 2026 Apr 19. |
| Τύπος έκδοσης: | Journal Article |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE |
| Imprint Name(s): | Publication: Oxford : Wiley-Blackwell Original Publication: London, Macmillan Journals Ltd. |
| Ιατρικοί όροι (MeSH): | Antidepressive Agents*/adverse effects , Pharmacists*/psychology , Pharmacists*/statistics & numerical data , Drug Monitoring*/methods , Attitude of Health Personnel* , Community Pharmacy Services*, Humans ; Female ; Male ; Belgium ; Surveys and Questionnaires ; Adult ; Middle Aged ; Professional Role ; Cross-Sectional Studies |
| Περίληψη: | This study assessed pharmacists' experiences and perspectives on monitoring antidepressant adverse events. A stratified sample of 1000 community pharmacists in Dutch-speaking Belgium was invited to complete an online survey on general views on adverse event monitoring and antidepressant adverse event monitoring practice at first and second dispensing and after 1 year. Descriptive statistics were used for analysis. The response rate was 24.4% (244/1000). Overall, pharmacists generally reported positive attitudes towards monitoring antidepressant adverse events, although less positive than for other medicines. Although pharmacists felt well-positioned and trained to monitor adverse events, their approach remains largely passive. Most pharmacist informed patients at first dispensing, but only 47% proactively inquired at second dispensing and 9% at dispensing after 1 year. Only 19% felt comfortable discussing sexual dysfunction. In conclusion, despite community pharmacists' positive perspectives, proactive monitoring declined over time highlighting the need for patient, healthcare provider and policy level interventions. (© 2026 British Pharmacological Society.) |
| References: | Middleton N, Gunnell D, Whitley E, Dorling D, Frankel S. Secular trends in antidepressant prescribing in the UK, 1975‐1998. J Public Health Med. 2001;23(4):262‐267. doi:10.1093/pubmed/23.4.262. Bogowicz P, Curtis HJ, Walker AJ, Cowen P, Geddes J, Goldacre B. Trends and variation in antidepressant prescribing in English primary care: a retrospective longitudinal study. BJGP Open. 2021;5(4):BJGPO.2021.0020. doi:10.3399/BJGPO.2021.0020. Directie Farmaceutisch Beleid, Dienst voor Geneeskundige Verzorging. MORSE 2024 (gegevens 2022‐2023). National Institute for Health and Disability Insurance (INAMI‐RIZIV); 2024 [cited 2025 May 26]. Available from: https://www.riziv.fgov.be/SiteCollectionDocuments/morse_report_2024.pdf. Moore M, Yuen HM, Dunn N, Mullee MA, Maskell J, Kendrick T. Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. BMJ. 2009;339(oct15 2):b3999. doi:10.1136/bmj.b3999. The Scottish Government. Quality prescribing for antidepressants: guide for improvement 2024 to 2027. Edinburgh: The Scottish Government; 2024 [cited 2025 May 26]. Available from: https://www.gov.scot/publications/quality-prescribing-antidepressants-guide-improvement-2024-2027/. Johnson CF, Macdonald HJ, Atkinson P, Buchanan AI, Downes N, Dougall N. Reviewing long‐term antidepressants can reduce drug burden: a prospective observational cohort study. Br J Gen Pract. 2012;62(604):e773‐e779. doi:10.3399/bjgp12X658304. Horowitz M, Taylor D. The Maudsley deprescribing guidelines: antidepressants, benzodiazepines, gabapentinoids and Z‐drugs. Wiley; 2024:592. Taylor D, Barnes TRE, Young AH. The Maudsley prescribing guidelines in psychiatry. 13th ed. Wiley; 2018:872. Van Poelgeest EP, Pronk AC, Rhebergen D, Van der Velde N. Depression, antidepressants and fall risk: therapeutic dilemmas‐a clinical review. Eur Geriatr Med. 2021;12(3):585‐596. doi:10.1007/s41999‐021‐00475‐7. Sterke CS, van Beeck EF, van der Velde N, et al. New insights: dose‐response relationship between psychotropic drugs and falls: a study in nursing home residents with dementia. J Clin Pharmacol. 2012;52(6):947‐955. doi:10.1177/0091270011405665. Seppala LJ, Wermelink A, de Vries M, et al. Fall‐risk‐increasing drugs: a systematic review and meta‐analysis: II. Psychotropics. J am Med Dir Assoc. 2018;19(4):371.e11‐371.e17. Johnson CF, Maxwell M, Williams B, Dougall N, MacGillivray S. Dose‐response effects of selective serotonin reuptake inhibitor monotherapy for the treatment of depression: systematic review of reviews and meta‐narrative synthesis. BMJ Med. 2022;1(1):e000017. doi:10.1136/bmjmed‐2021‐000017. Johnson CF, Dougall NJ, Williams B, MacGillivray SA, Buchanan AI, Hassett RD. Patient factors associated with SSRI dose for depression treatment in general practice: a primary care cross sectional study. BMC Fam Pract. 2014;15:210. doi:10.1186/s12875‐014‐0210‐9. National Institute for Health and Care Excellence. Depression in adults: treatment and management (National Guideline 222). National Institute for Health and Care Excellence; 2022 [cited 2025 May 26]. Available from: https://www.nice.org.uk/guidance/ng222. Claassen N, Groeneweg BF, Heineman H, et al. NHG‐Standaard Depressie. Nederlands Huisartsen Genootschap (NHG); 2024 [cited 2025 May 26]. Available from: https://richtlijnen.nhg.org/standaarden/depressie. Declercq T, Habraken H, Van den Ameele H, Callens J, De Lepeleire J, Cloetens H. Richtlijn voor goede medische praktijkvoering: Depressie bij volwassenen. Domus Medica vzw; 2017 [cited 2025 May 26]. Available from: https://www.domusmedica.be/richtlijnen/depressie-bij-volwassenen. InterMutualistisch Agentschap. IMA Atlas: Geneesmiddelengebruik Antidepressiva. Intermutualistisch Agentschap VZW; 2022 [cited 2025 May 26]. Available from: https://aim-ima.be/IMA-Atlas. Lunghi C, Antonazzo IC, Burato S, et al. Prevalence and determinants of long‐term utilization of antidepressant drugs: a retrospective cohort study. Neuropsychiatr Dis Treat. 2020;16:1157‐1170. doi:10.2147/NDT.S241780. Mojtabai R, Olfson M. National trends in long‐term use of antidepressant medications: results from the U.S. National Health and nutrition examination survey. J Clin Psychiatry. 2014;75(2):169‐177. doi:10.4088/JCP.13m08443. Johnson CF, Williams B, MacGillivray SA, Dougall NJ, Maxwell M. Doing the right thing': factors influencing GP prescribing of antidepressants and prescribed doses. BMC Fam Pract. 2017;18(1):72. doi:10.1186/s12875‐017‐0643‐z. da Costa FA, Van Mil FJW, Alvarez‐Risco A. The pharmacist guide to implementing pharmaceutical care. Springer Nature Switzerland AG; 2019:506. Lelubre M, Wuyts J, Maesschalck J, et al. Implementation study of an intermediate medication review in Belgian community pharmacies. Res Social Adm Pharm. 2019;15(6):710‐723. doi:10.1016/j.sapharm.2018.09.002. World Health Organization. Joint FIP/WHO guidelines on good pharmacy practice: standards for quality of pharmacy services. World Health Organization; 2011 [cited 2025 May 26]. Available from: https://www.who.int/publications/m/item/annex-8-trs-961. Scheerder G, De Coster I, Van Audenhove C. Pharmacists' role in depression care: a survey of attitudes, current practices, and barriers. Psychiatr Serv. 2008;59(10):1155‐1160. doi:10.1176/ps.2008.59.10.1155. Soliman M. Pharmaceutical care in depression: a survey of stigma, confidence, attitudes, and barriers. Risk Manag Healthc Policy. 2020;13:2611‐2620. doi:10.2147/RMHP.S273365. Liekens S, Smits T, Laekeman G, Foulon V. Pharmaceutical care for people with depression: Belgian pharmacists' attitudes and perceived barriers. Int J Clin Pharmacol. 2012;34(3):452‐459. doi:10.1007/s11096‐012‐9628‐0. McGahuey CA, Gelenberg AJ, Laukes CA, et al. The Arizona sexual experience scale (ASEX): reliability and validity. J Sex Marital Ther. 2000;26(1):25‐40. doi:10.1080/009262300278623. Uher R, Farmer A, Henigsberg N, et al. Adverse reactions to antidepressants. Br J Psychiatry. 2009;195(3):202‐210. doi:10.1192/bjp.bp.108.061960. Manninen SM, Polo‐Kantola P, Vahlberg T, Kero K. Patients with chronic diseases: is sexual health brought up by general practitioners during appointments? A web‐based study. Maturitas. 2022;160:16‐22. doi:10.1016/j.maturitas.2022.01.014. Guillaumie L, Moisan J, Grégoire JP, et al. Perspective of community pharmacists on their practice with patients who have an antidepressant drug treatment: findings from a focus group study. Res Social Adm Pharm. 2015;11(2):e43‐e56. doi:10.1016/j.sapharm.2014.07.180. |
| Contributed Indexing: | Keywords: antidepressants; community pharmacists; cross‐sectional; monitoring adverse events; pharmacists' attitudes; pharmacy practice |
| Substance Nomenclature: | 0 (Antidepressive Agents) |
| Entry Date(s): | Date Created: 20260420 Date Completed: 20260626 Latest Revision: 20260726 |
| Update Code: | 20260726 |
| PubMed Central ID: | PMC13370061 |
| DOI: | 10.1002/bcp.70571 |
| PMID: | 42003216 |
| Βάση Δεδομένων: | MEDLINE |
| ISSN: | 1365-2125 |
|---|---|
| DOI: | 10.1002/bcp.70571 |